0 Comentários
0 Compartilhamentos
2KB Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Feed de notícias
- EXPLORAR
-
Páginas
-
Grupos
-
Eventos
-
Blogs
-
Marketplace
-
Fóruns
-
Faça o login para curtir, compartilhar e comentar!
-
Ovarian Cancer Diagnostics and Therapeutics Market Trends Shaping Oncology CareThe global ovarian cancer diagnostics and therapeutics market is witnessing significant growth due to the increasing prevalence of ovarian cancer, rising awareness regarding early detection, and continuous advancements in precision medicine. Healthcare providers and pharmaceutical companies are investing heavily in innovative diagnostic technologies and targeted treatment approaches to improve...0 Comentários 0 Compartilhamentos 286 Visualizações 0 Anterior
-
Rising Demand in Oncology Therapeutics: Oncology Small Molecule Drugs Market Trends, Demand Analysis, and Forecast to 2031The Oncology Small Molecule Drugs Market is witnessing sustained growth as the global healthcare landscape continues to prioritize effective cancer treatment solutions. Small molecule drugs have become integral to oncology due to their ability to penetrate cells and target specific molecular pathways associated with tumor progression. These therapies are widely used across multiple cancer...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Antibody Drug Conjugates Market Expansion with New Cancer TherapiesNorth America currently holds a significant share in the antibody drug conjugates market due to strong research infrastructure and high healthcare spending. The presence of major pharmaceutical companies also supports regional growth. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023, registering...0 Comentários 0 Compartilhamentos 4KB Visualizações 0 Anterior
-
Asia-Pacific PDX Models Market Expands Through Precision Oncology ResearchAsia-Pacific Patient Derived Xenograft (PDX) Models Market Summary: According to the latest report published by Data Bridge Market Research, the Asia-Pacific Patient Derived Xenograft (PDX) Models Market CAGR Value The world-class Asia-Pacific Patient Derived Xenograft (PDX) Models Market report analyses some of the challenges that Asia-Pacific Patient Derived Xenograft (PDX) Models...0 Comentários 0 Compartilhamentos 563 Visualizações 0 Anterior
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Can RNA-Based Therapeutics Revolutionize Cancer Treatment?RNA-Based Cancer Therapeutics Market Summary: According to the latest report published by Data Bridge Market Research, the RNA-Based Cancer Therapeutics Market CAGR Value For structuring the finest market research report like this RNA-Based Cancer Therapeutics Market, a devoted team of experienced forecasters, well-versed analysts and knowledgeable researchers work...0 Comentários 0 Compartilhamentos 970 Visualizações 0 Anterior
-
Can Targeting Endocrine Resistance Unlock New Breakthroughs in Cancer Treatment?Executive Summary Endocrine Resistance–Targeting Drug Market Size and Share Analysis Report CAGR Value The global endocrine resistance–targeting drug market size was valued at USD 2.96 billion in 2025 and is expected to reach USD 8.50 billion by 2033, at a CAGR of 14.10% during the forecast period This Endocrine...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Expanding Horizons in Adult Malignant Glioma Therapeutics Market: Growth Opportunities, Strategies, and Forecast to 2031The global oncology sector is undergoing a significant transformation, driven by the rising prevalence of aggressive brain tumors such as malignant gliomas in adults. Increasing incidence rates, coupled with advancements in immunotherapy, targeted therapies, and precision medicine, are shaping a dynamic treatment landscape. Pharmaceutical and biotechnology companies are focusing on developing...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
How Are Synthetic Lethality Drugs Changing the Landscape of Precision Oncology?Regional Overview of Executive Summary Synthetic Lethality Drug Market Market by Size and Share CAGR Value The global Synthetic Lethality Drug market size was valued at USD 1.93 billion in 2025 and is expected to reach USD 8.07 billion by 2033, at a CAGR of 19.60% during the forecast period This Synthetic Lethality Drug Market report helps you to...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
-
Investment Trends in the Anti-cancer Drugs MarketThe increasing focus on biologics and biosimilars is transforming the anti-cancer drugs industry. These advanced therapies offer new treatment options for patients with complex cancers. Their rising adoption is expected to drive long-term market expansion. The Anti-cancer Drugs Market is anticipated to expand at a CAGR of 9.2% from 2026 to 2034, reflecting steady innovation and increasing...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
-
Is RNA-Based Therapy the Next Breakthrough in Cancer Treatment?Executive Summary RNA-Based Cancer Therapeutics Market Size and Share Across Top Segments CAGR Value The global RNA-based cancer therapeutics market size was valued at USD 415.8 million in 2025 and is expected to reach USD 947.1 million by 2033, at a CAGR of 10.80% during the forecast period Market drivers and market restraints covered in this...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Is Synthetic Lethality the Future Breakthrough in Targeted Cancer Therapy?Executive Summary Synthetic Lethality Drug Market Size and Share Analysis Report CAGR Value The global Synthetic Lethality Drug market size was valued at USD 1.93 billion in 2025 and is expected to reach USD 8.07 billion by 2033, at a CAGR of 19.60% during the forecast period This Synthetic Lethality Drug Market research report guides the...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Oncology Small Molecule Drugs Market Growth Factors, Opportunities, Drivers, Strategies, Trends, and Forecast to 2031The Oncology Small Molecule Drugs Market is experiencing accelerated interest and investment as global healthcare systems intensify efforts to improve cancer care outcomes. According to the Oncology Small Molecule Drugs Market report by The Insight Partners, this market is anticipated to grow at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2031, underscoring sustained momentum in...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
Páginas impulsionada
Patrocinado
Patrocinado
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek